Ryo Morimoto

Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort

Tracy Ann Williams, Jacques W.M. Lenders, Paolo Mulatero et al. · The Lancet Diabetes & Endocrinology · 2017 · 945 citations · Full text

Medicine, Endocrinology, Surgery +14

Liquid Chromatography–Tandem Mass Spectrometry Analysis of Human Adrenal Vein 19-Carbon Steroids Before and After ACTH Stimulation

Juilee Rege, Yasuhiro Nakamura, Fumitoshi Satoh et al. · The Journal of Clinical Endocrinology & Metabolism · 2013 · 233 citations · Full text

Life Sciences, Biochemistry, Endocrinology +17

Cellular and Genetic Causes of Idiopathic Hyperaldosteronism

Kei Omata, Fumitoshi Satoh, Ryo Morimoto et al. · Hypertension · 2018 · 202 citations · Full text

Medicine, Endocrinology, Pathobiology +17

Immunohistochemistry of a Proliferation Marker Ki67/MIB1 in Adrenocortical Carcinomas: Ki67/MIB1 Labeling Index Is a Predictor for Recurrence of Adrenocortical Carcinomas

Ryo Morimoto, Fumitoshi Satoh, Osamu Murakami et al. · Endocrine Journal · 2008 · 141 citations · Full text

Medicine, Oncology, Pathology +17

SLCO4C1 Transporter Eliminates Uremic Toxins and Attenuates Hypertension and Renal Inflammation

Takafumi Toyohara, Takehiro Suzuki, Ryo Morimoto et al. · Journal of the American Society of Nephrology · 2009 · 136 citations

Medicine, Molecular Biology, Pharmacology +12